ADHF clinical trials at UCSF

1 research study open to eligible people

ADHF means the heart suddenly has trouble pumping blood and can lead to hospital stays. UCSF is testing if the Aortix device works better than common medicines like diuretics. This helps understand how to treat people with long-term heart failure.

Showing trials for

  • Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

    open to eligible people ages 21 years and up

    Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.

    San Francisco, California and other locations

Our lead scientists for ADHF research studies include .

Last updated: